Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130507
Status:
TERMINATED
Last Update Posted:
2019-02-26
First Post:
2005-08-12
Brief Title:
Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab
Sponsor:
Spanish Breast Cancer Research Group
Organization:
Spanish Breast Cancer Research Group